HISTIOCYTIC NEOPLASMS
Clinical trials for HISTIOCYTIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancer: ulixertinib trial launches
Disease control Recruiting nowThis study tests a drug called ulixertinib in 38 people with histiocytic neoplasms, a rare group of blood disorders. The goal is to see if the drug can shrink tumors or stop them from growing. Participants will take the drug and be monitored for side effects and response.
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New PET scan tracer could spot hidden cancers
Knowledge-focused Recruiting nowThis early-phase study is testing a new imaging agent called [68Ga]-pentixafor to see how well it lights up certain blood cancers and related disorders on PET/CT scans. About 30 adults with non-Hodgkin lymphoma, multiple myeloma, or histiocytic neoplasms will receive the agent an…
Matched conditions: HISTIOCYTIC NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated May 25, 2026 01:27 UTC